ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Alvogen Inks Agreement with Exeltis
June 20, 2019Acquires a targeted portfolio of 23 prescription and OTC drugs in the field of women’s healthcare. -
Exeltis USA, Inc. Announces the Approval of Slynd (drospirenone), the First and Only Progestin-Only Pill Providing Pregnancy Prevention with a 24/4 Dosing Regimen and 24-hour Missed Pill Window
June 11, 2019Exeltis USA, Inc. Announces the Approval of Slynd (drospirenone), the First and Only Progestin-Only Pill Providing Pregnancy Prevention with a 24/4 Dosing Regimen and 24-hour Missed Pill Window. -
FDA Accepts Filing of New Estrogen-free Oral Contraceptive Slinda (drospirenone) Developed by Exeltis
December 03, 2018The pharmaceutical multinational Exeltis, with a strong position in Women's Health, has received acceptance from the US Food and Drug Administration (FDA) of the filing.....
Pharma Sources Insight January 2025
